Release Date: 04/08/15 08:24 Summary: Leading Software Company to Evaluate Spookfish Technology Price Sensitive: Yes Download Document 49.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%